Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of metabolism/homeostasis (HP:0001939)help
Parent Node:
expand
Abnormality of temperature regulation (HP:0004370)help
..Starting node
..expand
Malignant hyperthermia (HP:0002047)help
Term ID: 2047
Name: Malignant hyperthermia
Synonym: Malignant hyperthermia with anaesthesia; Malignant hyperthermia with anesthesia
Definition: Malignant hyperthermia is characterized by a rapid increase in temperature to 39-42 degrees C in response to inhalational anesthetics such as halothane or to muscle relaxants such as succinylcholine.
Comments:
Reference: HP:0002047
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandFever (HP:0001945) help
..expandHeat intolerance (HP:0002046) help
..expandHypothermia (HP:0002045) help
..expandobsolete Impaired thermal sensitivity (HP:0006901) help
..expandTemperature instability (HP:0005968) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002047HP:0002047Malignant hyperthermia0ABCA12 CL E G H2615414637ORPHA:457Harlequin ichthyosisHP:0040283 - Occasional130
HP:0002047HP:0002047Malignant hyperthermia0ATP2A1 CL E G H487811OMIM:601003BRODY MYOPATHY80
HP:0002047HP:0002047Malignant hyperthermia0BIN1 CL E G H2741052ORPHA:169189Autosomal dominant centronuclear myopathyHP:0040284 - Very rare99
HP:0002047HP:0002047Malignant hyperthermia0CACNA1S CL E G H7791397ORPHA:423Malignant hyperthermia of anesthesiaHP:0040282 - Frequent247
HP:0002047HP:0002047Malignant hyperthermia0CHRNA1 CL E G H11341955OMIM:253290Multiple pterygium syndrome, Lethal type.74
HP:0002047HP:0002047Malignant hyperthermia0CHRND CL E G H11441965OMIM:253290Multiple pterygium syndrome, Lethal type.88
HP:0002047HP:0002047Malignant hyperthermia0CHRNG CL E G H11461967OMIM:253290Multiple pterygium syndrome, Lethal type.68
HP:0002047HP:0002047Malignant hyperthermia0CLCF1 CL E G H2352917412ORPHA:1545Crisponi syndromeHP:0040281 - Very frequent6
HP:0002047HP:0002047Malignant hyperthermia0CRLF1 CL E G H92442364ORPHA:1545Crisponi syndromeHP:0040281 - Very frequent24
HP:0002047HP:0002047Malignant hyperthermia0DNM2 CL E G H17852974ORPHA:169189Autosomal dominant centronuclear myopathyHP:0040284 - Very rare167
HP:0002047HP:0002047Malignant hyperthermia0EDAR CL E G H109132895ORPHA:1810Autosomal dominant hypohidrotic ectodermal dysplasiaHP:0040283 - Occasional86
HP:0002047HP:0002047Malignant hyperthermia0EDARADD CL E G H12817814341ORPHA:1810Autosomal dominant hypohidrotic ectodermal dysplasiaHP:0040283 - Occasional56
HP:0002047HP:0002047Malignant hyperthermia0ELP1 CL E G H85185959ORPHA:1764Familial dysautonomiaHP:0040281 - Very frequent133
HP:0002047HP:0002047Malignant hyperthermia0HSPG2 CL E G H33395273ORPHA:800Schwartz-Jampel syndromeHP:0040283 - Occasional345
HP:0002047HP:0002047Malignant hyperthermia0HSPG2 CL E G H33395273OMIM:255800Schwartz-jampel syndrome, type 1.345
HP:0002047HP:0002047Malignant hyperthermia0KDF1 CL E G H12669526624ORPHA:1810Autosomal dominant hypohidrotic ectodermal dysplasiaHP:0040283 - Occasional1
HP:0002047HP:0002047Malignant hyperthermia0MTMR14 CL E G H6441926190ORPHA:169189Autosomal dominant centronuclear myopathyHP:0040284 - Very rare7
HP:0002047HP:0002047Malignant hyperthermia0MYF6 CL E G H46187566ORPHA:169189Autosomal dominant centronuclear myopathyHP:0040284 - Very rare19
HP:0002047HP:0002047Malignant hyperthermia0MYH3 CL E G H46217573OMIM:193700Arthrogryposis, distal, type 2A166
HP:0002047HP:0002047Malignant hyperthermia0MYH3 CL E G H46217573ORPHA:2053Freeman-Sheldon syndromeHP:0040282 - Frequent166
HP:0002047HP:0002047Malignant hyperthermia0NALCN CL E G H25923219082ORPHA:2053Freeman-Sheldon syndromeHP:0040282 - Frequent48
HP:0002047HP:0002047Malignant hyperthermia0PGM1 CL E G H52368905OMIM:614921Congenital disorder of glycosylation, type It58
HP:0002047HP:0002047Malignant hyperthermia0RYR1 CL E G H626110483ORPHA:169189Autosomal dominant centronuclear myopathyHP:0040284 - Very rare1200
HP:0002047HP:0002047Malignant hyperthermia0RYR1 CL E G H626110483ORPHA:597Central core diseaseHP:0040282 - Frequent1200
HP:0002047HP:0002047Malignant hyperthermia0RYR1 CL E G H626110483OMIM:117000Central core diseaseHP:0040283 - Occasional1200
HP:0002047HP:0002047Malignant hyperthermia0RYR1 CL E G H626110483ORPHA:424107Congenital myopathy with myasthenic-like onsetHP:0040282 - Frequent1200
HP:0002047HP:0002047Malignant hyperthermia0RYR1 CL E G H626110483ORPHA:466650Exercise-induced malignant hyperthermiaHP:0040281 - Very frequent1200
HP:0002047HP:0002047Malignant hyperthermia0RYR1 CL E G H626110483OMIM:619542KING-DENBOROUGH SYNDROME; KDS1200
HP:0002047HP:0002047Malignant hyperthermia0RYR1 CL E G H626110483ORPHA:423Malignant hyperthermia of anesthesiaHP:0040282 - Frequent1200
HP:0002047HP:0002047Malignant hyperthermia0RYR1 CL E G H626110483OMIM:145600Malignant hyperthermia, susceptibility to, 1.1200
HP:0002047HP:0002047Malignant hyperthermia0SCN4A CL E G H632910591ORPHA:682Hyperkalemic periodic paralysisHP:0040283 - Occasional263
HP:0002047HP:0002047Malignant hyperthermia0SCN5A CL E G H633110593OMIM:272120Sudden infant death syndrome.1134
HP:0002047HP:0002047Malignant hyperthermia0STAC3 CL E G H24632928423OMIM:255995Myopathy, congenital, bailey-bloch.14
HP:0002047HP:0002047Malignant hyperthermia0STAC3 CL E G H24632928423ORPHA:168572Native American myopathyHP:0040282 - Frequent14
HP:0002047HP:0002047Malignant hyperthermia0TRAF6 CL E G H718912036ORPHA:1810Autosomal dominant hypohidrotic ectodermal dysplasiaHP:0040283 - Occasional
HP:0002047HP:0002047Malignant hyperthermia0TRAPPC9 CL E G H8369630832ORPHA:352530Intellectual disability-obesity-brain malformations-facial dysmorphism syndromeHP:0040281 - Very frequent158


Genes (26) :ABCA12 ATP2A1 BIN1 CACNA1S CHRNA1 CHRND CHRNG CLCF1 CRLF1 DNM2 EDAR EDARADD ELP1 HSPG2 KDF1 MTMR14 MYF6 MYH3 NALCN PGM1 RYR1 SCN4A SCN5A STAC3 TRAF6 TRAPPC9

Diseases (24) :ORPHA:457 OMIM:601003 ORPHA:169189 ORPHA:423 OMIM:253290 ORPHA:1545 ORPHA:1810 ORPHA:1764 ORPHA:800 OMIM:255800 OMIM:193700 ORPHA:2053 OMIM:614921 ORPHA:597 OMIM:117000 ORPHA:424107 ORPHA:466650 OMIM:619542 OMIM:145600 ORPHA:682 OMIM:272120 OMIM:255995 ORPHA:168572 ORPHA:352530
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.